Plaquenil (Hydroxychloroquine): Uses, Benefits, and Eye Safety

Information and Articles

Plaquenil (Hydroxychloroquine): Uses, Benefits, and Eye Safety

Plaquenil (generic name hydroxychloroquine) is a medication that was originally developed to treat malaria. Today, it is most commonly prescribed for certain autoimmune diseases (illnesses where the immune system attacks the body by mistake). This page will explain what conditions Plaquenil is used for, why doctors prescribe it, how it helps patients, and why taking the proper dose and getting regular eye check-ups are important to prevent vision loss.

Table of Contents:

Diseases and Conditions Treated with Plaquenil

Plaquenil is typically prescribed for the following diseases and conditions:

  • Lupus (Systemic Lupus Erythematosus, SLE): An autoimmune disease in which the immune system attacks healthy parts of the body (such as the joints, skin, and organs). Plaquenil helps manage lupus symptoms (including a skin form of lupus called discoid lupus that causes skin rashes).
  • Rheumatoid Arthritis (RA): An autoimmune form of arthritis where the immune system attacks the lining of the joints, causing pain, swelling, and stiffness. Plaquenil is used as a long-term treatment to reduce joint inflammation and prevent joint damage in RA.
  • Juvenile Idiopathic Arthritis (JIA): A type of arthritis in children. Plaquenil is sometimes used to treat this childhood arthritis to help control joint pain and swelling.
  • Malaria: A disease caused by parasites. Plaquenil can prevent and treat malaria by killing the parasite that causes the illness. (In practice, other medicines are now more commonly used for malaria, but Plaquenil is still effective for this purpose.)

Lupus (Systemic Lupus Erythematosus)

Lupus is a long-term autoimmune disease, which means the body’s immune system mistakenly attacks its own healthy cells and tissues, causing inflammation and damage in many parts of the body. In lupus, the immune system (which normally protects you from germs) becomes overactive and can harm organs such as the skin, joints, kidneys, heart, lungs, blood cells, and brain. Lupus can range from mild to life-threatening, and it often flares up (gets worse) and then goes into remission (gets better) unpredictably. There is no cure yet, but early diagnosis and proper treatment can help manage the disease.

Lupus affecting skin and patients use Plaquenil to treat

How Lupus Affects the Body (Immune System Involvement)

Because lupus is an autoimmune disorder, the immune system loses the ability to tell the difference between foreign invaders and the body’s own cells. This leads the immune system to attack the body’s own tissues by mistake. The result is inflammation (swelling and irritation) in various organs. For example, lupus can cause inflammation in the joints, leading to pain and arthritis-like symptoms. It can inflame the skin, causing rashes. It may also affect internal organs – for instance, lupus can inflame the kidneys (lupus nephritis), the lining of the heart or lungs, or even the brain and blood vessels. Over time, this immune system attack can cause permanent tissue damage if not controlled. Treatments for lupus often include medications that calm down the immune system to prevent it from attacking the body.

Common Symptoms of Lupus

People with lupus can have many different symptoms, and not everyone has the same ones. Some typical symptoms include:

  • Extreme tiredness (fatigue) – Feeling very tired is the most common symptom of lupus. This fatigue can make it hard to do daily activities.
  • Joint pain and swelling – Lupus often causes pain or swelling in the joints (similar to arthritis). Many patients experience achy, stiff joints, especially in the hands, wrists, and knees.
  • Skin rashes – A butterfly-shaped rash on the face (across the nose and cheeks) is a classic sign of lupus. Lupus can also cause other rashes or spots on the skin, especially after being in the sun.
  • Fever – Many people with lupus have unexplained fevers (often low-grade) from time to time.
  • Hair loss and mouth sores – Thinning hair and painless sores in the mouth or nose are also common symptoms.

Some people may have other symptoms or complications depending on which organs are affected. For example, lupus can make you sensitive to sunlight (causing your skin to break out in a rash). It can cause chest pain when taking a deep breath if the lining around the lungs or heart is inflamed. In some cases, lupus causes kidney problems (leading to leg swelling), blood clots, anemia (low red blood cells), or headaches and confusion if the brain is involved. It’s important to remember that no two cases of lupus are exactly alike – one person might have mostly skin and joint issues, while another could have kidney or heart involvement.

Who Is Most Commonly Affected by Lupus?

Anyone can develop lupus (including men and children), but it is far more common in certain groups:

  • Women: About 9 out of 10 adults with lupus are women. Women of childbearing age (approximately 15 to 44 years old) have the highest risk of developing lupus.
  • Age: Lupus most often begins in young to middle adulthood. It commonly starts between the late teens and 40s, but it can also occur in childhood or later in life.
  • Race/Ethnicity: Lupus is more common – and often more severe – in people of color. In the United States, Black/African American, Hispanic/Latino, Asian, and American Indian/Alaska Native people are affected more often than White people. For example, Black and American Indian/Alaska Native women are 2 to 3 times more likely to develop lupus than White women, and they tend to have more severe disease symptoms. Hispanic and Asian women also have higher rates of lupus than White women.

Why Are These Groups More Affected by Lupus?

Scientists are still studying why lupus is much more common in women and certain ethnic groups. There is no single clear cause, but experts believe a combination of factors is responsible:

  • Hormones (Biological Sex Differences): Female hormones, such as estrogen, are thought to play a role. Lupus often strikes women during their childbearing years when estrogen levels are highest, so researchers suspect that estrogen may increase immune system activity and contribute to lupus. This might help explain why women get lupus far more often than men.
  • Genetics (Inherited Factors): Lupus tends to run in some families, which suggests genes are important. Certain gene variations (especially those involved in immune system function) are more common in people who develop lupus. People from African, Hispanic, Asian, or Native American ancestry may have genetic traits that make the immune system more prone to lupus. Researchers think genes are one reason lupus affects minority groups at higher rates or with more severity. However, having a genetic risk doesn’t mean someone will definitely get lupus – it only makes it more likely if other triggers occur.
  • Environment and Triggers: Environmental factors likely trigger lupus in people who are genetically susceptible. Examples of triggers include infections (viruses), severe stress, smoking, certain medications, or even sunlight exposure. For instance, sun exposure can provoke skin rashes or flares in many people with lupus. These factors alone don’t cause lupus, but in someone whose genes make them prone to lupus, a trigger could kickstart the disease.

In summary, women (especially young women of color) have the highest risk for lupus, possibly due to a mix of hormonal influences and genetic predisposition. Researchers are continuing to study these issues to understand lupus better. It’s important to note that lupus is not contagious – you can’t catch it from someone else. It’s a disorder of the immune system influenced by biology and genetics, not an infectious disease.


Rheumatoid Arthritis (RA)

Rheumatoid arthritis (RA) is a chronic (long-lasting) autoimmune arthritis – the most common autoimmune form of arthritis. In RA, the body’s immune system attacks the lining of the joints by mistake, causing inflammation (swelling) inside the joints. Over time, this immune attack can damage the joint tissues. RA mainly affects the joints of the hands, wrists, and knees, but it can involve other joints and even other organs in the body in some cases. The joint damage from RA leads to pain, stiffness, swelling, and can eventually result in deformed joints or loss of joint function if not treated. RA is different from osteoarthritis, which is the wear-and-tear arthritis many older people get – RA’s damage comes from the immune system causing inflammation rather than just aging joints. There is no cure for RA yet, but treatments (medications and lifestyle changes) can help manage symptoms and slow down joint damage.

Rheumatoid arthritis (RA) affecting joints and patients use Plaquenil to treat

How RA Affects the Body (Immune System Involvement)

RA is driven by an abnormal immune response. Normally, the immune system defends us against infections. In RA, the immune system instead targets the synovium – this is the lining of membranes around the joints. The result is chronic inflammation in the joint lining. This inflammation causes the joint lining to thicken and release chemicals that can damage the cartilage and bone of the joint over time. As a result, the joints become painful, swollen, and stiff. People with RA often notice these effects in multiple joints, and usually on both sides of the body. For example, both hands or both knees might be affected in a similar way – this symmetrical pattern is a hallmark of RA. The immune system’s attack doesn’t always stay confined to the joints; RA can also cause inflammation in other parts of the body. Some people with RA develop issues like dry eyes, lung inflammation, heart problems, or small hard lumps under the skin called rheumatoid nodules. The reasons why the immune system goes awry in RA are not fully understood, but researchers think a mix of genes and environmental triggers (like smoking or certain infections) can start the process years before symptoms appear.

Common Symptoms of RA

Rheumatoid arthritis usually comes on gradually with symptoms that can worsen over time. Common signs and symptoms include:

  • Joint pain and stiffness: RA typically causes aching or pain in more than one joint. Stiffness is very common, especially morning stiffness that can last 30 minutes or longer after waking up. People often feel stiff after resting for a while, and it may improve with gentle movement.
  • Joint swelling and warmth: The affected joints become tender, red, warm, and visibly swollen due to inflammation. RA often starts in the small joints of the hands and feet, making fingers, knuckles, or toes puffy and sore. Joints on both sides of the body are usually affected in a similar way (for example, both left and right wrists).
  • Fatigue and weakness: RA is not just a joint disease; it can make you feel generally ill or tired. Many people with RA feel fatigue (extreme tiredness) and a lack of energy. They might also feel weak or have a harder time doing daily tasks during flare-ups.
  • Fever and weight loss: Some individuals experience low-grade fevers when their RA is active, as well as unintended weight loss or loss of appetite. This is because RA is a systemic (whole-body) inflammatory condition.

Other symptoms and related problems can occur as well. For example, RA can lead to difficulty with hand movements (like gripping objects) when hand joints are inflamed. Some people get firm lumps under the skin near joints (rheumatoid nodules), or notice dry eyes and dry mouth if RA affects tear and saliva glands. It’s also possible to have flare-ups, when symptoms get worse for a period of time, followed by periods of remission where symptoms ease off. RA affects everyone a bit differently, but ongoing joint pain with morning stiffness lasting more than an hour is a key sign that doctors look for.

Who Is Most Commonly Affected by RA?

RA can affect people of any age, but it most commonly begins in adulthood and is strongly linked to certain demographic factors:

  • Age: The risk of developing rheumatoid arthritis increases with age. RA is most often diagnosed in middle-aged and older adults. In fact, the highest rates of RA onset are in people around 50–60 years old. (There is a form of arthritis in children called juvenile idiopathic arthritis, but that is a separate condition related to RA in kids.) Many patients first notice RA symptoms in their 30s, 40s, or 50s, though it can start later as well. It’s less common for RA to start in very young adults, and rare in children (aside from the juvenile form).
  • Sex: Women are much more likely to develop RA than men. About 70–75% of people with RA are women. Another way to say this is that women are about 2 to 3 times more likely to have RA compared to men. RA can occur in men too, but it’s seen in women most of the time.
  • Race/Ethnicity: Rheumatoid arthritis occurs in all ethnic and racial groups worldwide. Unlike lupus, which is more common in certain minorities, RA’s prevalence across different groups is less dramatically uneven – however, studies have noted some differences. For example, some Native American populations have very high rates of RA (up to four times higher than in European-descended populations). On the other hand, some studies suggest that people of Asian descent have slightly lower rates of RA than other groups. In the United States, arthritis in general (including RA and other types) has been found to be more common among American Indian/Alaska Native adults, and tends to cause more severe joint pain in Black and Hispanic patients compared to Whites. It’s important to note that RA can affect anyone, regardless of ethnicity – the disease is found all over the world. The most significant risk factors are age and sex (being an older adult and female).

Why Are These Groups More Affected by RA?

There are several reasons why certain groups have a higher risk of RA:

  • Biological Sex and Hormones: The fact that women get RA more often than men suggests that hormonal factors might be involved. Researchers believe that female hormones (like estrogen) or other differences in the immune system between sexes could influence RA risk. Many women with RA experience changes in their disease during times of hormonal change (for instance, RA symptoms often improve during pregnancy and then flare up after pregnancy), supporting the idea that hormones play a role. However, the exact reason women are more prone to RA is not fully understood. It could be a mix of hormones and genetics.
  • Age Factors: RA is more likely to appear in mid to later life, possibly because the immune system can become easier to trigger as people age. Older adults have had more years of exposure to potential environmental triggers (such as infections or smoking) that might kickstart the abnormal immune response of RA. Additionally, with age, the body’s immune regulation might change and joints may be more susceptible to damage. In essence, the cumulative effects of aging and environment over time increase the chances of developing RA, which is why we see it more in people in their 50s than in their 20s.
  • Genetics and Family History: Just like lupus, rheumatoid arthritis has a genetic component. If you have family members with RA, your risk is higher, indicating that certain genes make a person more susceptible. For example, specific variations in immune system genes (such as the HLA-DR genes) are linked to a greater risk of RA. These genes are more common in some ethnic groups (one reason some Native American groups have very high RA rates is the higher frequency of certain risk genes in those populations). Still, genes alone do not determine fate – many people with a genetic risk never develop RA unless other factors intervene.
  • Environmental and Lifestyle Triggers: Among all groups, smoking tobacco is one of the strongest known risk factors for RA. Long-term smoking can roughly double the risk of getting RA and tends to make the disease more severe. This might contribute to higher RA rates in communities with higher smoking prevalence. Other factors like chronic gum disease (periodontitis) and certain infections have been associated with RA development as well. Lower socioeconomic status (e.g., growing up in a lower-income household) has been linked to higher RA risk, possibly due to increased exposure to childhood second-hand smoke or other stressors. These factors don’t target a specific race or sex, but they can influence why some individuals or populations get RA more frequently.

In summary, women and older adults are the most affected by RA. Women’s increased risk may be partly due to hormonal differences, although research is ongoing. Older people’s higher risk is likely because of cumulative exposures and age-related changes in the immune system. Genetics underlies some of these patterns – people with a family history or certain ethnic backgrounds (like some Native American groups) have gene combinations that predispose them to RA. But even with genetic risk, environmental factors such as smoking can greatly increase the chance of developing RA. RA is a complex disease with many influences, and scientists are continuing to study why it strikes certain people more than others. What we do know is that early recognition and treatment of RA can help all patients manage their symptoms better and prevent serious joint damage, no matter their demographic group.


Why Do Doctors Prescribe Plaquenil?

Doctors often prescribe Plaquenil because it can improve patients’ symptoms and help control the disease over time. Key reasons include:

  • Relief of Symptoms: Plaquenil reduces inflammation, which means it can lessen joint pain, swelling, and stiffness. In people with lupus, it can also help clear up skin rashes caused by the disease. Many patients begin to feel less pain and discomfort after taking Plaquenil for a few months.
  • Prevention of Flares and Damage: Plaquenil is a disease-modifying drug, which means it doesn’t just mask symptoms – it helps keep the disease itself under control. Studies have shown that patients on Plaquenil have fewer disease flare-ups (periods when the illness suddenly gets worse) and may avoid long-term damage to their organs or joints. In lupus, for example, Plaquenil has been linked to a lower chance of severe flares and can protect against irreversible organ damage over time. This can improve patients’ quality of life and even their long-term survival.

Another reason Plaquenil is prescribed is that it is generally well-tolerated. Unlike some stronger immunosuppressant drugs or long-term steroids, Plaquenil has a long track record of safety for most patients when used properly. It is often used in combination with other treatments (for example, with methotrexate for rheumatoid arthritis) to better control disease activity. Plaquenil’s benefits usually build up slowly – it may take a couple of months (up to 8–12 weeks) before a patient notices major improvements, so doctors advise patients to keep taking it as directed even if the effects are not immediate.


How Plaquenil Helps (How It Works)

Plaquenil helps patients by calming an overactive immune system. In autoimmune diseases like lupus and RA, the body’s immune system is overactive and attacks healthy tissues. Plaquenil works by slowing down the immune system’s hyperactivity. In simple terms, it tells the immune system to “cool down.” By doing this, Plaquenil reduces the inflammation (swelling and irritation) that causes pain and tissue damage in these diseases.

This immune-calming effect means Plaquenil is not just treating the outward symptoms, but actually helping to control the underlying cause of the disease. With less immune system attack on the body, patients have fewer symptoms and their disease is less likely to flare up or cause serious damage. For example, in lupus, Plaquenil can decrease the number of flare-ups and even reduce risks of complications like blood clots and organ damage over the long term. In rheumatoid arthritis, slowing the immune attack helps prevent ongoing joint damage. Overall, Plaquenil’s way of working leads to a steadier, milder disease course for many people.

(Note: Plaquenil was first discovered as an anti-malarial medicine. In malaria, it works differently – it kills the malaria parasite. But when treating autoimmune conditions, its main role is to modulate the immune system.)


Preventing Vision Loss: Proper Dosage and Eye Screening

One of the most important safety considerations with Plaquenil is its effect on the eyes. Plaquenil can build up in the eyes and cause damage to the retina (the light-sensing layer at the back of the eye) – a problem known as Plaquenil toxicity. This risk increases based on time and the dosage of Plaquenil. If retinal damage does occur, it can lead to vision loss. The eye damage can be serious and potentially permanent if it’s not caught early. Fortunately, there are clear guidelines to prevent unnecessary vision loss while taking Plaquenil. Patients and doctors can work together to use Plaquenil safely by following these precautions:

  • Take the Proper Dose: Always take Plaquenil exactly as prescribed by your doctor. The dose is usually set based on your body weight to make sure it’s not too high. Sticking to the recommended dose helps minimize the risk of eye toxicity.
  • Get Regular Eye Exams: Eye screening is essential for everyone on Plaquenil. Doctors typically recommend getting a thorough eye exam soon after starting Plaquenil (within the first year of treatment) and then routine yearly eye check-ups after several years on the drug, or sooner if certain risk factors are present. An eye doctor (typically an ophthalmologist) will check your retina for any early signs of Plaquenil toxicity. Regular screening can catch any changes early, before they affect your vision. In fact, at a bare minimum, most doctors recommend an eye exam every year once you’ve been on Plaquenil for 5 years or more (some doctors suggest yearly exams even sooner).
  • Report Vision Changes Immediately: While on Plaquenil, pay attention to your eyesight. If you notice any vision changes – for example, blurred vision, difficulty reading, missing spots in your vision, or seeing flashes of light – inform your doctor right away. These could be early signs of a problem. By stopping the medication early if toxicity is detected, doctors can prevent permanent damage. Always be open about any new symptoms with your healthcare providers.

By following the proper dosage and screening guidelines, the risk of unnecessary vision loss is low. Doctors prescribe Plaquenil because it can be effective for conditions like lupus and rheumatoid arthritis – it helps control the disease and prevent organ damage. The key is simply to use Plaquenil safely: take the right dose and get your eyes properly checked. This way, patients can enjoy the benefits of this medicine while avoiding unnecessary vision loss.

Plaquenil Lawyers are here to help.

We’ll get to the truth and pursue the justice you deserve.

› Get a FREE Case Review!

Latest Posts

Plaquenil (Hydroxychloroquine): Uses, Benefits, and Eye Safety

Plaquenil (Hydroxychloroquine): Uses, Benefits, and Eye Safety Plaquenil (generic name hydroxychloroquine) is a medication that was originally developed to treat malaria. Today, it is most commonly prescribed for certain autoimmune diseases (illnesses where the immune…

Plaquenil Side Effects: What Every Patient Should Discuss with Their Doctor

Plaquenil (hydroxychloroquine) can be an effective treatment for autoimmune conditions, but it carries potential risks, particularly for the eyes. Knowing the side effects and communicating with your doctor is crucial for safety. Common Side Effects of Plaquenil…

Top 5 Eye Tests to Detect Plaquenil Toxicity Before It’s Too Late

Plaquenil toxicity is a serious risk for patients taking hydroxychloroquine, a medication commonly prescribed for lupus, rheumatoid arthritis, and other autoimmune conditions. While Plaquenil can be highly effective in controlling these diseases, long-term use can…

We're ready to talk